Company Filing History:
4 out of 811 
4 out of 260 
Years Active: 2019-2025
Title: David Shook: Innovator in Cancer Treatment
Introduction
David Shook is a notable inventor based in Memphis, TN (US), recognized for his contributions to the field of cancer treatment. With a total of four patents to his name, he has made significant strides in the development of innovative therapies utilizing natural killer (NK) cells.
Latest Patents
Among his latest patents is the invention titled "Natural killer cells expressing membrane-bound interleukin 15 (mbIL15) and uses thereof." This invention provides a natural killer (NK) cell that expresses all or a functional portion of interleukin-15 (IL-15), along with methods for producing such cells. The invention further outlines methods for using these NK cells to treat cancer in subjects or to enhance the expansion and/or survival of NK cells. Another significant patent is "Immune cells expressing membrane-bound interleukin 15 (mbIL15) and uses thereof," which shares similar applications and methodologies aimed at improving cancer treatment.
Career Highlights
David Shook has worked with prestigious institutions, including the National University of Singapore and St. Jude Children's Research Hospital. His work in these organizations has contributed to advancing research in immunotherapy and cancer treatment.
Collaborations
Some of his notable coworkers include Dario Campana and Masaru Imamura, who have collaborated with him on various research projects.
Conclusion
David Shook's innovative work in the field of cancer treatment through the development of NK cell therapies showcases his commitment to advancing medical science. His contributions are paving the way for new treatment options for cancer patients.